Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $334,549,072.08
Most recent insider trade:
  • March 28, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
March 28, 2024EVP24,602$88.34Sell$2,173,340.68
March 5, 2024Insider35,341$85.18Sell$3,010,346.38
March 5, 2024EVP4,000$87.07Sell$348,280.00
March 5, 2024Director1,000$85.51Sell$85,510.00
Feb. 27, 2024Director1,000$90.35Sell$90,350.00
Feb. 9, 2024Director15,000$88.28Sell$1,324,200.00
Jan. 9, 2024Director10,000$98.19Sell$981,900.00
Dec. 21, 2023Director10,000$93.99Sell$939,900.00
Dec. 13, 2023EVP13,764$95.30Sell$1,311,709.20
Aug. 16, 2023EVP5,000$90.00Sell$450,000.00
Aug. 10, 2023Insider12,000$90.43Sell$1,085,160.00
Aug. 8, 2023EVP11,000$89.42Sell$983,620.00
Aug. 7, 2023CEO4,000$88.10Sell$352,400.00
May 10, 2023CEO30,000$94.85Sell$2,845,500.00
April 10, 2023CEO10,000$99.56Sell$995,600.00
April 6, 2023CEO10,000$96.13Sell$961,300.00
April 3, 2023Director8,500$97.09Sell$825,265.00
March 13, 2023CEO8,000$90.45Sell$723,600.00
March 10, 2023CEO15,000$92.28Sell$1,384,200.00
Feb. 13, 2023CEO6,000$109.15Sell$654,900.00
Feb. 10, 2023CEO15,000$110.11Sell$1,651,650.00
Jan. 25, 2023EVP49,000$115.70Sell$5,669,300.00
Jan. 17, 2023CEO10,000$111.55Sell$1,115,500.00
Jan. 13, 2023CEO10,000$112.25Sell$1,122,500.00
Jan. 13, 2023CFO2,500$114.50Sell$286,250.00
Dec. 13, 2022CEO1,000$106.89Sell$106,890.00
Dec. 13, 2022CFO2,500$107.50Sell$268,750.00
Dec. 2, 2022CFO7,001$104.50Sell$731,604.50
Dec. 2, 2022CEO1,500$103.98Sell$155,970.00
Nov. 23, 2022CFO5,379$98.73Sell$531,068.67
Nov. 2, 2022EVP3,000$86.12Sell$258,360.00
Oct. 31, 2022CEO1,500$86.55Sell$129,825.00
Oct. 31, 2022Director3,625$86.75Buy$314,468.75
Oct. 14, 2022CEO4,000$89.89Sell$359,560.00
Aug. 15, 2022CEO3,000$95.21Sell$285,630.00
Aug. 12, 2022CEO4,000$94.75Sell$379,000.00
Aug. 11, 2022EVP3,000$95.62Sell$286,860.00
Aug. 8, 2022EVP6,205$96.56Sell$599,154.80
July 8, 2022EVP7,398$90.00Sell$665,820.00
July 8, 2022EVP, Chief Legal Officer7,398$90.00Sell$665,820.00
July 8, 2022EVP, Chief Financial Officer7,337$89.50Sell$656,661.50
May 26, 2022EVP1,308$78.94Sell$103,253.52
May 5, 2022CEO10,000$84.14Sell$841,400.00
May 4, 2022CFO11,800$84.50Sell$997,100.00
May 2, 2022EVP15,347$80.38Sell$1,233,591.86
May 2, 2022Director3,878$82.09Sell$318,345.02
April 28, 2022CEO20,000$83.79Sell$1,675,800.00
April 18, 2022CEO20,000$81.91Sell$1,638,200.00
April 14, 2022Director4,250$83.66Sell$355,555.00
April 14, 2022CEO10,000$83.66Sell$836,600.00
First«1 of 8»Last
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Dennis Slamon, Davis George Eric, Mueller Brian, David E I Pyott, Daniel K. Spiegelman, Charles Greg Guyer, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 151 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $174,722,571.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on March 28, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.